Wall Street Associates Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EOX
EMERALD OIL INC (MT)
EOX
|
+$8.31M |
| 2 |
Vanda Pharmaceuticals
VNDA
|
+$6.47M |
| 3 |
POWR
POWERSECURE INTL INC COM STK (DE)
POWR
|
+$5.81M |
| 4 |
Immersion
IMMR
|
+$4.73M |
| 5 |
Verastem
VSTM
|
+$4.58M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pacira BioSciences
PCRX
|
+$15.7M |
| 2 |
WAGE
WageWorks, Inc.
WAGE
|
+$14.6M |
| 3 |
CLVS
Clovis Oncology, Inc.
CLVS
|
+$13.2M |
| 4 |
BLOX
Infoblox Inc
BLOX
|
+$8.35M |
| 5 |
MODN
MODEL N, INC.
MODN
|
+$7.01M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.4% |
| 2 | Healthcare | 17.4% |
| 3 | Consumer Discretionary | 17.18% |
| 4 | Industrials | 14.81% |
| 5 | Energy | 4.49% |
Similar funds
Wall Street Associates's Q3 2013 Portfolio in Review
As of Q3 2013, Wall Street Associates held 331 positions worth $1.07B, up 9.3% from $981M the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Wall Street Associates withdrew a net $42M in Q3 2013, closing 30 positions and reducing 165 holdings. Its most notable exit was Infoblox Inc, an estimated $8.35M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Wall Street Associates opened a new position in EMERALD OIL INC (MT) worth $8.42M.
- Wall Street Associates's largest Q3 2013 buy was EMERALD OIL INC (MT): 58,550 shares worth $8.42M.
- Wall Street Associates added most to BowFlex Inc. in Q3 2013, an estimated $4.2M increase.
- Wall Street Associates's biggest Q3 2013 reduction was Pacira BioSciences, cutting an estimated $15.7M.
- Wall Street Associates fully exited Infoblox Inc in Q3 2013, selling an estimated $8.35M.
- Wall Street Associates's ten largest holdings make up 16% of its $1.07B portfolio in Q3 2013.
- Wall Street Associates opened 59 new positions and closed 30 in Q3 2013.
- Wall Street Associates's portfolio value rose 9.3% quarter-over-quarter to $1.07B.
Based on Wall Street Associates's 13F filing for Q3 2013, filed 12 Nov 2013.